| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
353,650
|
344,003
|
357,433
|
349,326
| | Cost of Revenue | 245,124 | 220,812 | 245,481 | 230,800 | | |
Gross Profit
|
108,526
|
123,191
|
111,952
|
118,526
| |
|
Operating Expenses |
|
Research Development | 44,082 | 40,700 | 42,978 | 42,881 |
|
Selling General and Administrative | 40,126 | 43,794 | 37,866 | 40,134 |
|
Non Recurring | 7,199 | 5,437 | 243 | 1,141 |
|
Others | 7,603 | 7,729 | 7,742 | 7,444 |
|
|
|
Total Operating Expenses | 99,010 | 97,660 | 88,829 | 91,600 | | | |
Operating Income or Loss
|
9,516
|
25,531
|
23,123
|
26,926
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (18,835) | 1,217 | 2,202 | 59 |
|
Earnings Before Interest And Taxes | (9,319) | 26,748 | 25,325 | 26,985 |
|
Interest Expense | 4,631 | 4,546 | 4,479 | 4,422 |
|
Income Before Tax | (13,950) | 22,202 | 20,846 | 22,563 |
|
Income Tax Expense | 700 | 7,407 | 2,982 | 7,562 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (14,650) | 14,795 | 17,864 | 15,001 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(14,650)
|
14,795
|
17,864
|
15,001
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(14,650)
|
14,795
|
17,864
|
15,001
|
|
0.20(1.23%) 10:40AM EDT - Nasdaq Real Time Price